Compare Stocks

Fort Dearborn Income Securities, Inc. (the Fund) is a diversified closed-end management investment company. The Fund's primary objective is to provide shareholders with a stable stream of current income consistent with external interest rate conditions and provide a total return over time that is above what they could receive by investing individually in the investment grade and long-term maturity sectors of the bond market. The Fund invests in corporate bonds, collateralized debt obligations, commercial mortgage-backed securities, mortgage and agency debt securities, municipal bonds, the United States Government obligations and residential mortgage-backed securities, among others. The Fund has investments in various industry sectors, such as automobiles, banks, biotechnology, building products, capital markets, chemicals, construction materials, consumer finance, diversified financial services and electric utilities. Its investment advisor is UBS Asset Management (Americas), Inc.

Sphinx Resources Ltd. engages in the acquisition, exploration, and development of mineral properties in Canada. It explores for zinc, copper, nickel, lead, palladium, platinum, gold, and silver deposits. The company holds interests in various properties located in the Pontiac regional county municipality of southwestern Québec; and in southern Abitibi Temiscaming region and southeast of the municipality of Saint-Édouard-de-Fabre. The company was formerly known as Donner Metals Ltd. and changed its name to Sphinx Resources Ltd. in October 2014. Sphinx Resources Ltd. was incorporated in 2005 and is headquartered in Montreal, Canada.

TNR Gold Corp. engages in the acquisition, exploration, and evaluation of mineral properties. The company explores for gold, copper, silver, and lithium deposits. It holds a 90% interest in the Shotgun gold project located in the southwestern Alaska. The company also holds royalty interests in the Los Azules Copper and Mariana Lithium projects located in Argentina. TNR Gold Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software products for treating cancer and other medical conditions worldwide. It operates through Oncology Systems and Proton Solutions segments. The Oncology Systems segment offers hardware and software products for treating cancer with radiotherapy, fixed field intensity-modulated radiation therapy, image-guided radiation therapy, volumetric modulated arc therapy, stereotactic radiosurgery, stereotactic body radiotherapy, artificial intelligence based adaptive radiotherapy, and brachytherapy, as well as quality assurance equipment. Its products include linear accelerators, brachytherapy afterloaders, treatment accessories, and quality assurance software; and information management, treatment planning, image processing, clinical knowledge exchange, patient care management, decision-making support, and practice management software. This segment serves university research and community hospitals, private and governmental institutions, healthcare agencies, physicians' offices, medical oncology practices, radiotherapy centers, and cancer care clinics. The Proton Solutions segment designs, develops, manufactures, sells, and services products and systems for delivering proton therapy for the treatment of cancer. The company has a strategic agreement with McKesson Corp. to supply treatment delivery systems and planning, services, and radiotherapy information system solutions to its U.S. Oncology Network and Vantage Oncology affiliated sites of care; and a strategic partnership with Siemens AG to represent Siemens diagnostic imaging products to radiation oncology clinics in the United States and other select markets. Varian Medical Systems, Inc. was formerly known as Varian Associates, Inc. and changed its name to Varian Medical Systems, Inc. in April 1999. The company was founded in 1948 and is headquartered in Palo Alto, California.